1
TÍTULO: In Silico Investigation of Caged Xanthone Compounds Isolated from Cratoxylum sumatranum Stem Bark Against Entamoeba histolytica Enzymes
AUTORES: Achmad Fuad Hafid; Defi Kartika Sari; Fendi Yoga Wardana; Mohammad Rizki Fadhil Pratama ; Lidya Tumewu; Hilkatul Ilmi; Adita Ayu Permanasari; Hanifah Khairun Nisa; Aty Widyawaruyanti;
PUBLICAÇÃO: 2023, FONTE: Letters in Drug Design & Discovery, VOLUME: 20
INDEXADO EM: CrossRef
NO MEU: ORCID
2
TÍTULO: Total Flavonoid, Total Phenolic contents and Antioxidant activity of Methanol and n-hexane extract from purple passion fruit peel
AUTORES: Khoirul Ngibad; Dheasy Herawati; Siti Delta Aisyah; Lailatul Jannah Triarini; Mohammad Rizki Fadhil Pratama ;
PUBLICAÇÃO: 2023, FONTE: Research Journal of Pharmacy and Technology, VOLUME: 16, NÚMERO: 3
INDEXADO EM: Scopus CrossRef
NO MEU: ORCID
3
TÍTULO: Bioactive Compounds from Mangosteen (Garcinia mangostana L.) as an Antiviral Agent via Dual Inhibitor Mechanism against SARS-CoV-2: An In Silico Approach  Full Text
AUTORES: Ansori A.N.M.; Kharisma V.D.; Parikesit A.A.; Dian F.A.; Probojati R.T.; Rebezov M.; Scherbakov P.; Burkov P.; Zhdanova G.; Mikhalev A.; Antonius Y.; Pratama M.R.F. ; Sumantri N.I.; Sucipto T.H.; Zainul R.;
PUBLICAÇÃO: 2022, FONTE: Pharmacognosy Journal, VOLUME: 14, NÚMERO: 1
INDEXADO EM: Scopus CrossRef: 7
NO MEU: ORCID
4
TÍTULO: Boesenbergia Pandurata as an Anti-Breast Cancer Agent: Molecular Docking and ADMET Study
AUTORES: Mohammad Rizki Fadhil Pratama ; Ersanda Nurma Praditapuspa; Dini Kesuma; Hadi Poer Wono; Tri Widiandani; Siswandono Siswodihardjo;
PUBLICAÇÃO: 2022, FONTE: Letters in Drug Design and Discovery, VOLUME: 19, NÚMERO: 7
INDEXADO EM: Scopus CrossRef: 2
NO MEU: ORCID
5
TÍTULO: Design, synthesis, anti-acetylcholinesterase evaluation and molecular modelling studies of novel coumarin-chalcone hybrids
AUTORES: Aso Hameed Hasan; Sonam Shakya; Faiq H S Hussain; Sankaranarayanan Murugesan; Subhash Chander; Mohammad Rizki Fadhil Pratama ; Shajarahtunnur Jamil; Basundhara Das; Subhrajit Biswas; Joazaizulfazli Jamalis;
PUBLICAÇÃO: 2022, FONTE: Journal of Biomolecular Structure and Dynamics
INDEXADO EM: Scopus CrossRef: 3
NO MEU: ORCID
6
TÍTULO: Discovery of multitargeting inhibitors for the treatment of COVID-19: An in- silico studies
AUTORES: ASO HAMEED HASAN; Narmin Hamaamin Hussen; Sonam Shakya; Joazaizulfazli Jamalis; Mohammad Rizki Fadhil Pratama ; Subhash Chander; Harsha Kharkwal; Sankaranarayanan Murugesan;
PUBLICAÇÃO: 2022
INDEXADO EM: CrossRef
NO MEU: ORCID
7
TÍTULO: In silico discovery of multi-targeting inhibitors for the COVID-19 treatment by molecular docking, molecular dynamics simulation studies, and ADMET predictions
AUTORES: Hasan, AH; Hussen, NH; Shakya, S; Jamalis, J; Pratama, MRF ; Chander, S; Kharkwal, H; Murugesan, S;
PUBLICAÇÃO: 2022, FONTE: STRUCTURAL CHEMISTRY, VOLUME: 33, NÚMERO: 5
INDEXADO EM: Scopus WOS CrossRef: 14
NO MEU: ORCID
8
TÍTULO: Molecular Docking and DFT Study of Synthesized Oxazine Derivatives
AUTORES: Zinad, DS; Mahal, A; Salman, GA; Shareef, OA; Pratama, MRF ;
PUBLICAÇÃO: 2022, FONTE: EGYPTIAN JOURNAL OF CHEMISTRY, VOLUME: 65, NÚMERO: 7
INDEXADO EM: Scopus WOS CrossRef: 1
NO MEU: ORCID
9
TÍTULO: Novel thiophene Chalcones-Coumarin as acetylcholinesterase inhibitors: Design, synthesis, biological evaluation, molecular docking, ADMET prediction and molecular dynamics simulation  Full Text
AUTORES: Aso Hameed Hasan; Sankaranarayanan Murugesan; Syazwani Itri Amran; Subhash Chander; Mohammed M Alanazi; Taibi Ben Hadda; Sonam Shakya; Mohammad Rizki Fadhil Pratama ; Basundhara Das; Subhrajit Biswas; Joazaizulfazli Jamalis;
PUBLICAÇÃO: 2022, FONTE: Bioorganic Chemistry, VOLUME: 119
INDEXADO EM: Scopus CrossRef: 25
NO MEU: ORCID
10
TÍTULO: One-pot synthesis, molecular docking, ADMET, and DFT studies of novel pyrazolines as promising SARS-CoV-2 main protease inhibitors
AUTORES: Salih, RHH; Hasan, AH; Hussein, AJ; Samad, MK; Shakya, S; Jamalis, J; Hawaiz, FE; Pratama, MRF ;
PUBLICAÇÃO: 2022, FONTE: RESEARCH ON CHEMICAL INTERMEDIATES, VOLUME: 48, NÚMERO: 11
INDEXADO EM: Scopus WOS CrossRef: 5
NO MEU: ORCID
Página 1 de 6. Total de resultados: 51.